In summary, this work demonstrates that GRHL2, a key epithelial transcriptional regulator, can regulate extracellular adenosine levels produced by breast cancer cells through suppression of the gene encoding the NT5E/CD73 ecto-enzyme. This evidence concerns the gene GRHL2 and breast carcinoma.